 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
What Is the Appropriate Level of Blood-Thinning Medication for Elderly People with Atrial Fibrillation?
16 November 2004 | Volume 141 Issue 10 | Page I-38
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation." It is in the 16 November 2004 issue of Annals of Internal Medicine (volume 141, pages 745-752). The authors are M.C. Fang, Y. Chang, E.M. Hylek, J. Rosand, S.M. Greenberg, A.S. Go, and D.E. Singer.
What is the problem and what is known about it so far?
The heart usually beats with a regular rhythm controlled by electrical signals. These signals move like a wave from the top chambers of the heart (the atria) to the bottom chambers (the ventricles). In some people, however, the electrical signals become disorganized and make the muscles of the atria quiver rather than beat in an organized fashion. This condition, called atrial fibrillation, produces an irregular heart rhythm that increases the risk for forming blood clots inside the chambers of the heart. These blood clots can be pumped out into the vessels that send blood to the brain, causing a stroke. For this reason, doctors usually treat patients who have atrial fibrillation with blood thinners. Unfortunately, people receiving blood thinners are at risk for bleeding inside the skull (intracranial hemorrhage, or ICH). Elderly people are thought to be more susceptible to ICH when they are being treated with blood thinners. Recently, guidelines have been issued for doctors who treat patients with atrial fibrillation, suggesting that to avoid ICH, patients older than age 75 years who have never had a stroke be treated with lower doses of blood thinners than younger patients.
Why did the researchers do this particular study?
To find out if there was a relationship between patient age, level of blood thinning, and occurrence of ICH.
Who was studied?
One hundred seventy patients with atrial fibrillation who were being treated with blood thinners and had developed ICH were compared with 1020 similar patients who had not had ICH.
How was the study done?
This was a "case–control" study in which patients with a particular disease (cases) were compared with those without the disease (controls). The researchers identified all patients who were treated at the Massachusetts General Hospital for ICH and had been given blood thinners for management of atrial fibrillation (cases). They also identified similar patients being cared for in the blood-thinning clinic who had not had ICH (controls). Data were collected on characteristics of all patients, including age, sex, intensity of blood thinning (the international normalized ratio [INR]), and other medical conditions.
What did the researchers find?
Although the risk for ICH increased with age (particularly at age 85 years or older), a very low INR did not protect patients older than age 75 years from this complication. On the other hand, INRs above the recommended target range were associated with an increased incidence of ICH.
What were the limitations of the study?
The risk for ICH may have been affected by the duration of blood thinner treatment as well as INRs, but data were not available to test this possibility.
What are the implications of the study?
Using a very low dose of blood thinner in elderly patients with atrial fibrillation does not reduce the risk for ICH and may expose patients to unnecessarily high risk for stroke.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. Schulman, R. J. Beyth, C. Kearon, and M. N. Levine Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 257S - 298S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Toyoda, M. Yasaka, K. Iwade, K. Nagata, Y. Koretsune, T. Sakamoto, S. Uchiyama, J. Gotoh, T. Nagao, M. Yamamoto, et al. Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study Stroke, June 1, 2008; 39(6): 1740 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L Garwood and T. L Corbett Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls Ann. Pharmacother., April 1, 2008; 42(4): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N U Weir An update on cardioembolic stroke Postgrad. Med. J., March 1, 2008; 84(989): 133 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Fang, A. S. Go, Y. Chang, L. Borowsky, N. K. Pomernacki, D. E. Singer, and for the ATRIA Study Group Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation J. Am. Coll. Cardiol., February 26, 2008; 51(8): 810 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein and P. M. Rothwell Advances in Prevention and Health Services Delivery 2007 Stroke, February 1, 2008; 39(2): 258 - 260. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Schalekamp, J H. Klungel, P. C. Souverein, and A. de Boer Increased Bleeding Risk With Concurrent Use of Selective Serotonin Reuptake Inhibitors and Coumarins Arch Intern Med, January 28, 2008; 168(2): 180 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Taggar and G. Y.H. Lip Anticoagulation for elderly patients with atrial fibrillation: not to be neglected Europace, January 1, 2008; 10(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, October 16, 2007; 116(16): e391 - e413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hughes, G.Y.H. Lip, and on behalf of the Guideline Development Group for t Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review QJM, October 1, 2007; 100(10): 599 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, and W. Chen Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation J. Am. Coll. Cardiol., July 24, 2007; 50(4): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Hart, L. A. Pearce, and M. I. Aguilar Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation Ann Intern Med, June 19, 2007; 146(12): 857 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, June 1, 2007; 38(6): 2001 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Wyse Bleeding While Starting Anticoagulation for Thromboembolism Prophylaxis in Elderly Patients With Atrial Fibrillation: From Bad to Worse Circulation, May 29, 2007; 115(21): 2684 - 2686. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Hylek, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation Circulation, May 29, 2007; 115(21): 2689 - 2696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Mayo, L. Nadeau, S. S. Daskalopoulou, and R. Cote The evolution of stroke in Quebec: A 15-year perspective Neurology, April 3, 2007; 68(14): 1122 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Perez-Gomez, J. A. Iriarte, J. Zumalde, J. Berjon, A. Salvador, E. Alegria, M. P. Maluenda, S. Asenjo, R. Perez-Saldana, R. G. de la Torre, et al. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial Eur. Heart J., April 2, 2007; 28(8): 996 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kubitza, M. Becka, M. Zuehlsdorf, and W. Mueck Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59-7939) in Healthy Subjects J. Clin. Pharmacol., February 1, 2007; 47(2): 218 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Flaherty, B. Kissela, D. Woo, D. Kleindorfer, K. Alwell, P. Sekar, C. J. Moomaw, M. Haverbusch, and J. P. Broderick The increasing incidence of anticoagulant-associated intracerebral hemorrhage Neurology, January 9, 2007; 68(2): 116 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kakar, D. Lane, and G. Y. H. Lip Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema. Chest, November 1, 2006; 130(5): 1296 - 1299. [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nair, B. Sealove, J. L. Halperin, G. Webber, and V. Fuster Anticoagulation in patients with heart failure: who, when, and why? Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E32 - E38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): 700 - 752. [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030. [Full Text] [PDF]
|
|
|
|
|
|
K. Lakshminarayan, C. A. Solid, A. J. Collins, D. C. Anderson, and C. A. Herzog Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002) Stroke, August 1, 2006; 37(8): 1969 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Waikar, R. Wald, G. M. Chertow, G. C. Curhan, W. C. Winkelmayer, O. Liangos, M.-A. Sosa, and B. L. Jaber Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1688 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Ickx and A. Steib Perioperative management of patients receiving vitamin K antagonists: [Prise en charge perioperatoire des patients traites aux antagonistes de la vitamine K] Can J Anesth, June 1, 2006; 53(6_suppl): S113 - S122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Koennecke Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications Neurology, January 24, 2006; 66(2): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Wilke, R. L. Berg, H. J. Vidaillet, M. D. Caldwell, J. K. Burmester, and M. A. Hillman Impact of Age, CYP2C9 Genotype and Concomitant Medication on the Rate of Rise for Prothrombin Time During the First 30 Days of Warfarin Therapy Clin. Med. Res., November 1, 2005; 3(4): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Fang, D. E. Singer, Y. Chang, E. M. Hylek, L. E. Henault, N. G. Jensvold, and A. S. Go Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study Circulation, September 20, 2005; 112(12): 1687 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, S. B. Tonarelli, and L. A. Pearce Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas Stroke, July 1, 2005; 36(7): 1588 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Ruiz-Ruiz Warfarin or Not Warfarin? Ann Intern Med, April 19, 2005; 142(8): 676 - 676. [Full Text] [PDF]
|
|
|
|
|
|
J. Marti, E. Anton, D. Smadja, and S. Olindo Stroke in the Very Elderly * Response Stroke, April 1, 2005; 36(4): 705 - 706. [Full Text] [PDF]
|
|
|
|
 |
|
 Which Afib Patients on Warfarin Are at Risk for Intracranial Hemorrhage? Journal Watch Cardiology, January 14, 2005; 2005(114): 3 - 3. [Full Text]
|
|
|
|
 |
|
 Risk for Intracranial Hemorrhage Among Warfarin Users with Atrial Fibrillation Journal Watch (General), December 21, 2004; 2004(1221): 1 - 1. [Full Text]
|
|
Read all Rapid Responses
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
